Active Surveillance for Prostate Cancer

A safe, evidence-based option for selected men with early prostate cancer

Not every prostate cancer needs immediate treatment. For many men with early localised disease, active surveillance is a safe and well-established approach that monitors the cancer closely with PSA tests, MRI scans and, in some cases, repeat biopsy, while delaying or avoiding treatments and their side effects.  Active surveillance can offer comparable survival outcomes to treatment while reducing overtreatment.

Table of Contents

What is Active Surveillance?

Active surveillance means monitoring prostate cancer carefully rather than treating it straight away. It is designed for men with small early tumours that unlikely to cause harm in the short to medium term, but who still need structured follow-up so that treatment can be started promptly if the cancer changes. This is not “doing nothing”, it is an active management strategy built around regular review, repeat PSA tests, imaging and clear triggers for intervention.

Action shot of Dr Benjamin Lamb during a prostate cancer procedure.

Who is suitable for Active Surveillance?

Active surveillance is usually considered for men with early localised low-risk prostate cancers (i.e. Gleason 3+3 or Cambridge Prognostic Group 1), and in selected cases of intermediate-risk disease (i.e. Gleason 3+4 or Cambridge Prognostic Group 2).  Active surveillance may be appealing if you  wish to avoid or delay side effects associated with surgery or radiotherapy, are comfortable with ongoing monitoring and understand that treatment may still be needed at a later date.

What does Active Surveillance involve?

A typical active surveillance programme includes:

  • Regular PSA blood tests, often every 3 to 4 months initially.
  • Multiparametric MRI scans at defined intervals to assess for change.
  • Repeat prostate biopsy in selected patients, particularly if the MRI features or PSA levels becomes more concerning.
  • Ongoing specialist review to decide whether surveillance remains appropriate.

Why choose Active Surveillance?

The main benefit of active surveillance is that it can help men avoid or postpone treatment and its side effects without compromising safety in appropriately selected and monitored cases. Advantages include avoiding or delaying urinary incontinence and sexual dysfunction associated with prostate surgery or radiotherapy, preserving quality of life while maintaining a route to treatment if needed, and reducing overtreatment of slow-growing cancers that may never become clinically significant during a patient’s lifetime. 

When might treatment become necessary?

Active surveillance does not mean treatment is ruled out forever. Treatment may be recommended if there is evidence that the cancer is getting worse over time.

Possible triggers for moving from surveillance to treatment include:

  • Rising PSA
  • MRI changes suggesting tumour growth or development of a new suspicious lesion
  • Repeat biopsy showing a higher-grade cancer
  • New symptoms or changing clinical factors
  • Anxiety around ongoing surveillance


If treatment becomes necessary, options may include robotic prostatectomy, radiotherapy or focal therapy depending on the nature and location of the cancer.

Active Surveillance versus watchful waiting

These terms are often confused, but they are not the same. Active surveillance is a structured cancer management strategy with the intention of offering curative treatment later if the disease changes, whereas watchful waiting is usually a less intensive approach focused on symptom monitoring in men for whom curative treatment is less likely to be appropriate.  For men who are fit and healthy, active surveillance is usually the more relevant option.

Questions to ask at a consultation

Useful questions include:

  • Is my cancer suitable for active surveillance?
  • How often will I need PSA tests, MRI scans and possible repeat biopsy?
  • What findings would trigger a recommendation for treatment?
  • If I leave surveillance later, what treatment options would still be available?
  • How is MRI quality and reporting handled in your surveillance pathway?
  • What can I do myself to reduce the cancer getting worse?

Interventions for men on Active Surveillance

  • Core message
    • The most important “intervention” is sticking to your active surveillance plan: attending PSA tests, MRI scans and biopsies when advised.
    • Any extras (tablets, supplements, lifestyle programmes) are still under study and are not proven to stop cancer progressing.

  • Lifestyle and general health
    • A healthy, balanced diet rich in vegetables, staying active, maintaining a healthy weight, not smoking and looking after mental health are strongly encouraged for overall wellbeing and cardiovascular risk, even though they have not clearly been shown to slow cancer progression on surveillance.
    • Structured exercise programmes improve weight, blood pressure and quality of life, but have not definitively reduced progression in trials.

  • Supplements that have been studied
    • Pomegranate / Pomi‑T®, omega‑3 fish oils and high‑dose vitamin D have shown some biological effects in small studies (e.g. slower PSA rise or biopsy changes), but evidence is mixed and not strong enough to recommend them routinely.
    • Coffee and increased vegetables appear safe and support general health, but have not clearly reduced progression in active surveillance cohorts.

  • Medications and novel therapies
    • Common drugs like statins and metformin have been investigated but have not shown clear, consistent benefit for slowing prostate cancer on surveillance.
    • Hormone‑related agents (5‑alpha reductase inhibitors, chlormadinone, short‑course ARPIs) and experimental treatments (Fexapotide, PROSTVAC) show some promising signals in early studies but also carry side effects and are not standard practice.

  • Conclusion
    • Interventions should be seen as optional extras for motivated men who understand the uncertainties and side effects, and only after discussion with their supervising clinician.
    • No supplement or pill removes the need for regular PSA, MRI and possible biopsy, and that decisions should be individualised.

Get in Touch

Get in touch with us today! Our dedicated team is here to assist you with any questions or concerns you may have. We encourage you to reach out to us via email, phone, or by filling out our convenient online form. Your inquiries are important to us, and we look forward to providing you with the support you need.

Resources

What you can do next with healthXY

Book an Appointment

Schedule a consultation with our specialists and start your health journey today.

Explore FAQs

Find answers to common questions about our services and appointment process.